임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
48건 표시
- 1/2상모집 중· Hemophilia AA Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
리드: 로슈
- 1/2상모집 중· Advanced Prostate CancerA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
리드: 로슈
- 1/2상모집 중· Thoracic Neoplasms, Lung Diseases, Small Cell Lung CarcinomaA Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
협력: 로슈
- 1/2상모집 중· Mantle Cell LymphomaGlofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial
협력: 로슈
- 1/2상모집 중단 (진행 중)· Moderate to Severe Ulcerative ColitisA Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis
리드: 로슈
- 1/2상모집 중· Huntington DiseaseA Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
리드: 로슈
- 1/2상모집 중· Advanced CholangiocarcinomaPhase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion
협력: 로슈
- 1/2상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)
리드: 로슈
- 1/2상모집 중· Diffuse Large B-Cell LymphomaMosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma
협력: 로슈
- 1/2상모집 중· Extensive Stage Lung Small Cell CarcinomaPhase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation
협력: 로슈
- 1/2상모집 중· Multiple MyelomaA Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
리드: 로슈
- 1/2상모집 중· Small Cell Lung Cancer (SCLC)A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
협력: 로슈
- 1/2상모집 중· Non-Small Cell Lung CancerA Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
리드: 로슈
- 1/2상모집 중· Mature B-Cell Non-Hodgkin LymphomaA Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
리드: 로슈
- 1/2상모집 중단 (진행 중)· AL AmyloidosisVenetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
협력: 로슈
- 1/2상모집 중· Endometrial CancerA Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
협력: 일라이 릴리, 화이자, 로슈
- 1/2상모집 중· ALK Fusion-positive Solid or CNS TumorsA Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
리드: 로슈
- 1/2상모집 중단 (진행 중)· Diffuse Large B Cell LymphomaA Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
협력: 로슈
- 1/2상모집 중· Inoperable, Locally Advanced or Metastatic, ER-positive Breast CancerA Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
리드: 로슈
- 1/2상모집 중단 (진행 중)· Metastatic Lung Non-Small Cell CarcinomaNecitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer
협력: 일라이 릴리, 로슈
- 1/2상모집 중단 (진행 중)· Chronic Myelomonocytic LeukemiaVenetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
협력: 로슈
- 1/2상모집 중단 (진행 중)· HER2-positive Breast CancerRadiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
협력: 로슈
- 1/2상모집 중단 (진행 중)· Macular DegenerationStudy of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration
리드: 로슈
- 1/2상모집 중단 (진행 중)· Advanced Solid TumorsA Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors
리드: 로슈
- 1/2상모집 중단 (진행 중)· Solid TumorsDose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
리드: 로슈
- 1/2상모집 중단 (진행 중)· Lymphoma, Non-HodgkinA Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
리드: 로슈
- 1/2상모집 중단 (진행 중)· B-cell Non-Hodgkin LymphomaA Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
리드: 로슈
- 1/2상모집 중단 (진행 중)· Non-Hodgkins LymphomaAn Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
리드: 로슈
- 1/2상모집 중· Metastatic Breast CancerA Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
리드: 로슈 · 협력: 길리어드, 화이자
- 1/2상모집 중단 (진행 중)· Non-small Cell Lung CancerA Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
협력: 로슈
- 1/2상모집 중단 (진행 중)· Bladder CancerA Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
협력: 로슈
- 1/2상모집 중단 (진행 중)· Paroxysmal Hemoglobinuria, NocturnalStudy to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria
리드: 로슈
- 1/2상모집 중단 (진행 중)· Age-Related Macular DegenerationSafety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
리드: 로슈
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.